|
|||||||||
|
|||||||||
 | |||||||||
 | |||||||||
|
Many RA patients who have partial responses to long-term etanercept or methotrexate monotherapy can be put into remission by combining these drugs... Rheumatology News Research shows that new onset knee pain was strongly linked with an increase of two or more units in bone marrow lesions... Ocera Therapeutics, Inc, a privately-held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat gastrointestinal (GI) and liver diseases, announced that it has completed patient enrollment of its double-blind, placebo-controlled phase III study in fistulizing Crohn’s disease...
Rheumatology News The fourth randomized clinical trial to test prolonged antibiotic therapy in patients previously treated for Lyme disease confirms the lack of lasting improvement in cognitive function reported in the early studies... Novartis Pharmaceuticals AG announced that Aclasta (zoledronic acid 5 mg) has received EU approval as the first once-yearly treatment for women with postmenopausal osteoporosis... |
|
 |
|
 Rheumatology and Infusion Therapy: Practice and Treatment Choices in the New Era | |
 The Scientific Basis of Individualized Treatment of Patients With RA: Online Byte-Size CME | |
To remove your e-mail address from our mailing list, please send a blank email to unsubscribe@fbhc.org. For questions and comments regarding this newsletter please contact info@ciaomed.org | |
